ArticleCancer investigation2023

Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma.

Chenyu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.